Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide

NCT00162760 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis (IPF)

Interventions

DRUG: Thalidomide

Sponsor

Johns Hopkins University

Collaborators

[object Object]